Matches in SemOpenAlex for { <https://semopenalex.org/work/W27979699> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W27979699 endingPage "52" @default.
- W27979699 startingPage "849" @default.
- W27979699 abstract "The development of secondary anaemia is a constant associated phenomenon of chronic renal failure. During its treatment by recombinant human erythropoietin (rHuEPO) erythropoiesis is accelerated and this increases demands on the supply of dietary erythropoietic precursors (Fe, pyridoxine, folic acid, vitamin B12). In particular as regards iron, frequently the dietary amount is not sufficient and supplementation is necessary. The objective of the present work is to compare oral and intravenous iron supplementation in the treatment of secondary anaemia by rHuEPO in patients with chronic renal failure treated by haemodialysis. A group of haemodialyzed patients (n = 61) treated with erythropoietin, where the serum ferritin concentration had dropped beneath 300 ng/ml, or the transferrin concentration below 0.20 was divided at random into two sub-groups. To group A Actiferrin was administered 3 x 1 cps/d (Ferrosi sulfas heptahydricus, corresponding to 34.5 mg elemental Fe and serine 129 mg per capsule, i.e. a total of 724.5 mg elemental Fe per week). To group A Ferrum-Lek was administered 1 vial per week by the i.v. route (Ferri oxidum saccharatum, corresponding to 100 mg elemental iron per week). The two groups were comparable as to the mean erythropoietin dose (50 U/kg per week) and the patients' mean age (61 years), the male/female ratio and the spectrum of basic diseases. After six weeks of treatment a comparable increase of the haematocrit and serum iron concentration was observed in both groups. As to transferrin saturation, there was a more marked increment in the intravenously supplemented group. The serum ferritin values in group A declined, while in group F they increased. After both types of iron supplementation a comparable increase of the haematocrit and serum iron concentration occurred, the iron reserves represented by serum ferritin differed however and from the long-term aspect they are in favour of intravenous iron supplementation in haemodialyzed patients treated with erythropoietin." @default.
- W27979699 created "2016-06-24" @default.
- W27979699 creator A5023108004 @default.
- W27979699 creator A5035017368 @default.
- W27979699 creator A5085244036 @default.
- W27979699 creator A5085637931 @default.
- W27979699 date "1996-12-01" @default.
- W27979699 modified "2023-09-23" @default.
- W27979699 title "[Iron supplementation during erythropoietin therapy in patients on hemodialysis]." @default.
- W27979699 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9072885" @default.
- W27979699 hasPublicationYear "1996" @default.
- W27979699 type Work @default.
- W27979699 sameAs 27979699 @default.
- W27979699 citedByCount "2" @default.
- W27979699 countsByYear W279796992019 @default.
- W27979699 crossrefType "journal-article" @default.
- W27979699 hasAuthorship W27979699A5023108004 @default.
- W27979699 hasAuthorship W27979699A5035017368 @default.
- W27979699 hasAuthorship W27979699A5085244036 @default.
- W27979699 hasAuthorship W27979699A5085637931 @default.
- W27979699 hasConcept C126322002 @default.
- W27979699 hasConcept C134018914 @default.
- W27979699 hasConcept C153852466 @default.
- W27979699 hasConcept C22814914 @default.
- W27979699 hasConcept C2777417653 @default.
- W27979699 hasConcept C2778063415 @default.
- W27979699 hasConcept C2778248108 @default.
- W27979699 hasConcept C2778319317 @default.
- W27979699 hasConcept C2778534260 @default.
- W27979699 hasConcept C2779875672 @default.
- W27979699 hasConcept C2993356106 @default.
- W27979699 hasConcept C71924100 @default.
- W27979699 hasConcept C90924648 @default.
- W27979699 hasConceptScore W27979699C126322002 @default.
- W27979699 hasConceptScore W27979699C134018914 @default.
- W27979699 hasConceptScore W27979699C153852466 @default.
- W27979699 hasConceptScore W27979699C22814914 @default.
- W27979699 hasConceptScore W27979699C2777417653 @default.
- W27979699 hasConceptScore W27979699C2778063415 @default.
- W27979699 hasConceptScore W27979699C2778248108 @default.
- W27979699 hasConceptScore W27979699C2778319317 @default.
- W27979699 hasConceptScore W27979699C2778534260 @default.
- W27979699 hasConceptScore W27979699C2779875672 @default.
- W27979699 hasConceptScore W27979699C2993356106 @default.
- W27979699 hasConceptScore W27979699C71924100 @default.
- W27979699 hasConceptScore W27979699C90924648 @default.
- W27979699 hasIssue "12" @default.
- W27979699 hasLocation W279796991 @default.
- W27979699 hasOpenAccess W27979699 @default.
- W27979699 hasPrimaryLocation W279796991 @default.
- W27979699 hasRelatedWork W1510274049 @default.
- W27979699 hasRelatedWork W1573006836 @default.
- W27979699 hasRelatedWork W2019494479 @default.
- W27979699 hasRelatedWork W2111249486 @default.
- W27979699 hasRelatedWork W2252422281 @default.
- W27979699 hasRelatedWork W2383632328 @default.
- W27979699 hasRelatedWork W2387575600 @default.
- W27979699 hasRelatedWork W2392277356 @default.
- W27979699 hasRelatedWork W2626510945 @default.
- W27979699 hasRelatedWork W3029248016 @default.
- W27979699 hasVolume "42" @default.
- W27979699 isParatext "false" @default.
- W27979699 isRetracted "false" @default.
- W27979699 magId "27979699" @default.
- W27979699 workType "article" @default.